Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.
Product overview
Start with the essentials
Authorized purpose: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Overview status: Source-reviewed overview
What does this software do?Authorized purpose: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: N/A Input: Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.
Who uses it?Intended users: Physicians using image review and image-guided diagnosis, treatment planning or treatment control applications.
What does the software produce?Output: Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
What is its most important limitation?Key limitation: Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.
Clinical takeaway
Clinical role: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Evidence takeaway
Evidence from the reviewed source record: FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.
Clinical details
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.
Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Radiological images; modality varies or is not specified in FDA list
FDA source
Exact FDA submission
Checked 2026-09-05
Existing broad catalog category preserved: the software spans radiographic, fluoroscopic/angiographic and cone-beam CT applications, including ultrasound fusion; it is not solely a CT product.
Existing unassigned catalog anatomy preserved because the general indication is multi-application. Individual modules address spine, cardiovascular, neurovascular, thorax, abdomen and pelvis; N/A does not mean no anatomic use.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.
No comparable product-wide sensitivity is established by the option-specific processing tests.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-05
No comparable product-wide specificity is established by the option-specific processing tests.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K254184 DynaCT Bone Removal validation
DesignStandalone segmentation comparison and separate clinical reader evaluation
Population180 reference-mask cases: 60 each thorax, abdomen and pelvis; separate 370 US/European datasets for reader evaluation
Scopeexact submission
Tested versionsyngo Application Software VE51A, DynaCT Bone Removal
Samplen=180
IndependenceSponsor or vendor study
K254184
Sample size denotes reference-mask cohort only; reader cohort is not added to it as a unique patient total.
DesignProspective multicenter non-inferiority comparison of sine-spin flat-detector CT with multidetector CT
PopulationAdults with suspected ischemic or hemorrhagic stroke and feasible noncontrast syngo DynaCT Sine Spin within four hours of reference CT
Scopeproduct family
Tested versionsyngo DynaCT Sine Spin; no VE51A linkage established
IndependenceSponsor or vendor study
NCT05458908
University Hospital Basel sponsor with Siemens Healthineers collaborator. Registry design context only; no trial result or exact-release diagnostic performance promoted.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-09-05
VE51A hardware, upgrade and individual-option prices were not established from reviewed sources; obtain an optionized quote.
Reimbursement and coding
Research pending
Needs research
Exact FDA submission
Checked 2026-09-05
No applicable payer policy was reviewed for the software or its individual interventional applications.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-06
Downloaded exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.
Buyer worksheet
Open questions to take to the vendor
Verify security and privacy controls: Submission cybersecurity testing is not a current site-specific security certification, patch-support contract or network assessment.
Verify training: Role-specific VE51A option training and site acceptance materials were not established.
Verify pricing and total cost: VE51A hardware, upgrade and individual-option prices were not established from reviewed sources; obtain an optionized quote.
Verify reimbursement and coding relevance: No applicable payer policy was reviewed for the software or its individual interventional applications.
Verify local validation and lifecycle monitoring: Post-installation performance monitoring and remote-service responsibilities require confirmation.
Verify recalls and postmarket safety signals: Downloaded exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-05Last searched
12Fields reviewed
10Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
Stored trial metadata screened and indexed primary registry content reviewed. SPINNERS retained as family design context, not VE51A results. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, clinical trial registry, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall
Sources & history
How this profile was documented
Open the ledger for source dates, scope, and research-record updates.
View source ledger and history7 sources - 3 history items
Beijing Infervision Healthcare Medical Technology Co., Ltd.
InferOperate Suite supports trained healthcare professionals in reading, interpreting, reporting, and treatment planning from medical images, with the submission's...
Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Chest; abdomen; pelvis; and general patient anatomy represented in supported images
Clever One is dental imaging software for trained professionals to view and interpret DICOM images from CT, panoramic, cephalometric, intraoral, and other imaging equipment, with...
Modality
Radiological images; modality varies or is not specified in FDA list